ASPIVIX Selected Among 4 EVC Finalists - 2017 - Aspivix

ASPIVIX Selected Among 4 EVC Finalists – 2017

October 10, 2017

Share this story:

More from our blog

Breaking Barriers at Aspivix

Breaking Barriers at Aspivix™

Aspivix Featured in a $360B Women’s Health Ghost Market Report

Aspivix Featured in a $360B Women’s Health Ghost Market Report

Aspivix on television in La Télé VAUD FRIBOURG!

Aspivix on TV in La Télé VAUD FRIBOURG!

ASPIVIX featured in New Lines Magazine on gentle gynecological innovation.

The Medical Instrument Behind 135 Years of Women’s Pain

Aspivix is mentioned on this Femtech Article by The Venturist.

Exploring Femtech

Blog Article to report about a Video on Youtube talking about Aspivix as a new cervical device designed for gentle gynecology

New Cervical Device Designed for Gentle Gynecology

Aspivix Selected as Finalist for the 2024 Digital Health Hub Foundation: Digital Health Awards

Aspivix and Tia Partner to Enhance IUD procedures with Carevix™ across the USA

CDC Issues new Guidelines on pain management for IUD procedures

CDC issues new guidelines on pain management for IUD procedures

Aspivix Announces MHRA Approval for the Groundbreaking Cervical Stabilizer Carevix™ for a painless contraceptive care in the United Kingdom